PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 281 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 6.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,354,000 | -74.6% | 44,131 | -66.9% | 0.20% | -73.0% |
| Q2 2023 | $5,337,000 | +35.7% | 133,195 | +38.2% | 0.73% | +29.4% |
| Q1 2023 | $3,932,000 | +6.7% | 96,356 | +1.0% | 0.56% | +6.2% |
| Q4 2022 | $3,684,000 | -27.4% | 95,414 | -0.0% | 0.53% | -32.4% |
| Q3 2022 | $5,077,000 | -5.8% | 95,443 | +3.3% | 0.79% | -2.6% |
| Q2 2022 | $5,388,000 | -24.5% | 92,415 | -1.1% | 0.81% | -9.0% |
| Q1 2022 | $7,132,000 | – | 93,448 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |